Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: Insights from the e-Cypher S.T.L.L.R. Trial

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 7, 2009, Pages 890-897

  Suzuki, Nobuaki ^a,b   Angiolillo, Dominick J ^a   Tannenbaum, Mark A ^c   Driesman, Mitchell H ^d   Smith, Conrad ^e   Bikkina, Mahesh ^f   Meckel, Clyde R ^g   Morales, Carlos E ^h   Xenopoulos, Nicholaos P ⁱ   Coletta, John E ^b   Bezerra, Hiram G ^b   Bass, Theodore A ^a   Costa, Marco A ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c IOWA HEART CENTER   (United States)

^d BRIDGEPORT HOSPITAL   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f ST JOSEPH S REGIONAL MEDICAL CENTER   (United States)

^g BryanLGH College of Health Sciences   (United States)

^h McAllen Heart Hospital   (United States)

ⁱ JEWISH HOSPITAL   (United States)

Author keywords

Angiography coronary; Percutaneous coronary intervention; Quantitative coronary angiography

Indexed keywords

ANTITHROMBOCYTIC AGENT; RAPAMYCIN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OPEN STUDY; PERCUTANEOUS CORONARY INTERVENTION; QUANTITATIVE ANALYSIS; REVASCULARIZATION; STENT THROMBOSIS; TREATMENT RESPONSE; UNITED STATES; VASODILATATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RISK ASSESSMENT; SIROLIMUS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 68249139776     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21796     Document Type: Article

References (37)

1. Suzuki N, Angiolillo DJ, Kawaguchi R, Futamatsu H, Bass TA, Costa MA. Percutaneous coronary intervention of bifurcation coronary disease. Minerva Cardioangiol 2007;55:57-71.
2. Chevalier B, Glatt B, Royer T, Guyon P. Placement of coronary stents in bifurcation lesions by the "culotte" technique. Am J Cardiol 1998;82:943-949.
3. Costa RA, Mintz GS, Carlier SG, Lansky AJ, Moussa I, et al. Bifurcation coronary lesions treated with the "crush" technique: An intravascular ultrasound analysis. J Am Coll Cardiol 2005;46:599-605.
4. Ge L, Airoldi F, Iakovou I, Cosgrave J, Michev I, et al. Clinical and angiographic outcome after implantation of drug-eluting stents in bifurcation lesions with the crush stent technique: Importance of final kissing balloon post-dilation. J Am Coll Cardiol 2005;46:613-620.
5. Lefevre T, Ormiston J, Guagliumi G, Schultheiss HP, Quilliet L, et al. The frontier stent registry: Safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions. J Am Coll Cardiol 2005;46:592-598.
6. Sharma SK. Simultaneous kissing drug-eluting stent technique for percutaneous treatment of bifurcation lesions in large-size vessels. Catheter Cardiovasc Interv 2005;65:10-16.
7. Jim MH, Ho HH, Miu R, Chow WH. Modified crush technique with double kissing balloon inflation (sleeve technique): A novel technique for coronary bifurcation lesions. Catheter Cardiovasc Interv 2006;67:403-409.
8. Ikeno F, Kim YH, Luna J, Condado JA, Colombo A, et al. Acute and long-term outcomes of the novel side access (SLK-view) stent for bifurcation coronary lesions: A multicenter non-randomized feasibility study. Catheter Cardiovasc Interv 2006; 67:198-206.
9. Hoye A, Iakovou I, Ge L, van Mieghem CA, Ong AT, et al. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: Predictors of an adverse outcome. J Am Coll Cardiol 2006;47:1949-1958.
10. Helqvist S, Jorgensen E, Kelbaek H, Aljabbari S, Thuesen L, et al. Percutaneous treatment of coronary bifurcation lesions: A novel "extended Y" technique with complete lesion stent coverage. Heart 2006;92:981-982.
11. Miyazawa A, Webster MW, Fitzgerald PJ, Ormiston JA. Novel stent system for bifurcation lesions: Examination by intravascular ultrasound. Catheter Cardiovasc Interv 2006;67:900-903.
12. Sharma SK, Choudhury A, Lee J, Kim MC, Fisher E, et al. Simultaneous kissing stents (SKS) technique for treating bifurcation lesions in medium-to-large size coronary arteries. Am J Cardiol 2004;94:913-917.
13. Al Suwaidi J, Yeh W, Cohen HA, Detre KM, Williams DO, Holmes DR Jr. Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). Am J Cardiol 2001;87:1139-1144.
14. Yamashita T, Nishida T, Adamian MG, Briguori C, Vaghetti M, et al. Bifurcation lesions: Two stents versus one stent - Immediate and follow-up results. J Am Coll Cardiol 2000;35:1145-1151.
15. Cervinka P, Stasek J, Pleskot M, Maly J. Treatment of coronary bifurcation lesions by stent implantation only in parent vessel and angioplasty in sidebranch: Immediate and long-term outcome. J Invasive Cardiol 2002;14:735-740.
16. Assali AR, Teplitsky I, Hasdai D, Rechavia E, Solodky A, et al. Coronary bifurcation lesions: To stent one branch or both? J Invasive Cardiol 2004;16:447-450.
17. Colombo A, Moses JW, Morice MC, Ludwig J, Holmes DR Jr, et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 2004;109: 1244-1249.
18. Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: The Nordic bifurcation study. Circulation 2006;114:1955-1961.
19. Pan M, de Lezo JS, Medina A, Romero M, Segura J, et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: A randomized comparison of a simple versus complex strategy. Am Heart J 2004;148:857-864.
20. Assali AR, Assa HV, Ben-Dor I, Teplitsky I, Solodky A, et al. Drug-eluting stents in bifurcation lesions: To stent one branch or both? Catheter Cardiovasc Interv 2006;68:891-896.
21. Costa MA, Angiolillo DJ, Tannenbaum M, Driesman M, Chu A, et al. Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (Final results of the multicenter prospective STLLR trial). Am J Cardiol 2008;101:1704-1711.
22. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-1029.
23. Medina A, Suarez de Lezo J, Pan M. A new classification of coronary bifurcation lesions. Rev Esp Cardiol 2006;59:183.
24. Costa MA, Sabate M, Angiolillo DJ, Hu P, Jimenez-Quevedo P, et al. Relocation of minimal luminal diameter after bare metal and drug-eluting stent implantation: Incidence and impact on angiographic late loss. Catheter Cardiovasc Interv 2007;69:181-188.
25. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
26. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: An evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004;109:1366-1370.
27. Lefevre T, Louvard Y, Morice MC, Dumas P, Loubeyre C, et al. Stenting of bifurcation lesions: Classification, treatments, and results. Catheter Cardiovasc Interv 2000;49:274-283.
28. Ge L, Tsagalou E, Iakovou I, Sangiorgi GM, Corvaja N, et al. In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent. Am J Cardiol 2005;95:757-760.
29. Moussa I, Costa RA, Leon MB, Lansky AJ, Lasic Z, et al. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique." Am J Cardiol 2006;97:1317-1321.
30. Galassi AR, Colombo A, Buchbinder M, Grasso C, Tomasello SD, et al. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique." Catheter Cardiovasc Interv 2007;69:976-983.
31. Ge L, Iakovou I, Cosgrave J, Agostoni P, Airoldi F, et al. Treatment of bifurcation lesions with two stents: One year angiographic and clinical follow up of crush versus T stenting. Heart 2006;92:371-376.
32. Brunel P, Lefevre T, Darremont O, Louvard Y. Provisional T-stenting and kissing balloon in the treatment of coronary bifurcation lesions: Results of the French multicenter "TULIPE" study. Catheter Cardiovasc Interv 2006;68:67-73.
33. Richter Y, Groothuis A, Seifert P, Edelman ER. Dynamic flow alterations dictate leukocyte adhesion and response to endovascular interventions. J Clin Invest 2004;113:1607-1614.
34. Ormiston JA, Webster MW, El Jack S, Ruygrok PN, Stewart JT, et al. Drug-eluting stents for coronary bifurcations: Bench testing of provisional side-branch strategies. Catheter Cardiovasc Interv 2006;67:49-55.
35. Vetrovec GW, Cowley MJ, Wolfgang TC, Ducey KC. Effects of percutaneous transluminal coronary angioplasty on lesion-associated branches. Am Heart J 1985;109(5 Part 1):921-925.
36. Boxt LM, Meyerovitz MF, Taus RH, Ganz P, Friedman PL, Levin DC. Side branch occlusion complicating percutaneous transluminal coronary angioplasty. Radiology 1986;161:681-683.
37. Meier B, Gruentzig AR, King SB III, Douglas JS Jr, Hollman J, et al. Risk of side branch occlusion during coronary angioplasty. Am J Cardiol 1984;53:10-14.